Synthesis and characterization of new tetrakisphosphonic acid derivatives as FPPS inhibitors and evaluation of their anti-osteoclastogenic potential for prevention of osteoporosis
Authors:
- 5 June 2024
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 33 (7) , 1167-1177
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Novel sulfonamide‐phosphonate conjugates as carbonic anhydrase isozymes inhibitorsDrug Development Research, 2023
- Microwave‐assisted synthesis of novel steroidal heterocyclic analogs as potent inhibitors of RANKL‐induced osteoclastogenesisDrug Development Research, 2023
- Pinner Reaction2021
- Radiopharmaceuticals for Bone Metastases2018
- Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153Applied Radiation and Isotopes, 2016
- Targeted delivery to bone and mineral deposits using bisphosphonate ligandsAdvanced Drug Delivery Reviews, 2016
- Risks and Benefits of Bisphosphonate TherapiesJournal of Cellular Biochemistry, 2015
- Novel antiosteoclastogenic activity of phloretin antagonizingRANKL‐induced osteoclast differentiation of murine macrophagesMolecular Nutrition & Food Research, 2012
- Name Reactions2009
- Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acidJournal of Cellular Physiology, 2007